Ipamorelin and GH Secretagogue Selectivity Research Ipamorelin was identified as the first GHRP-receptor agonist with a selectivity for GH release comparable to that of GHRH itself, making it a highly valuable research tool for studying the GH axis without unwanted hormonal interference
Tendon and Ligament Regeneration Pathways In rodent models of tendon injury, BPC-157 demonstrated increased fibroblast activity and collagen organization
Risk of incident dementia following metformin initiation compared with noninitiation or delay of antidiabetic medication therapy
The two modified strains were crossed by co-culture in YPD broth, and a diploid heterozygous strain (i.e
GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) became widely available through compounding pharmacies because the FDA placed them on its drug shortage list starting in 2022
GHRP6 acts on different receptor pathways than growth hormone-releasing hormone (GHRH), complementing its activity
